Abstract
In the context of transplantation, complement activation is associated with poor prognosis and outcome. While complement activation in antibody-mediated rejection is well-known, less is known about complement activation in acute T cell-mediated rejection (TCMR). There is increasing evidence that complement contributes to the clearance of apoptotic debris and tissue repair. In this regard, we have analysed published human kidney biopsy transcriptome data clearly showing upregulated expression of complement factors in TCMR. To clarify whether and how the complement system is activated early during acute TCMR, experimental syngeneic and allogeneic renal transplantations were performed. Using an allogeneic rat renal transplant model, we also observed upregulation of complement factors in TCMR in contrast to healthy kidneys and isograft controls. While staining for C4d was positive, staining with a C3d antibody showed no C3d deposition. FACS analysis of blood showed the absence of alloantibodies that could have explained the C4d deposition. Gene expression pathway analysis showed upregulation of pro-apoptotic factors in TCMR, and apoptotic endothelial cells were detected by ultrastructural analysis. Monocytes/macrophages were found to bind to and phagocytise these apoptotic cells. Therefore, we conclude that early C4d deposition in TCMR may be relevant to the clearance of apoptotic cells.
Highlights
Given the importance of renal transplantation (TX) and the limitation of available donor kidneys, a detailed analysis of factors that shorten graft survival is important
While complement upregulation was absent in nephrectomy and transplants without rejection (non-rejection (NR) samples), we found that the complement activation pathway (KEGG database pathway analysis) is significantly upregulated in T cell-mediated rejection (TCMR), ABMR, and mixed rejection (Figure 1A)
Since we hypothesised that apoptotic debris might be a trigger mechanism for complement expression, we investigated the apoptosis gene pathway
Summary
Given the importance of renal transplantation (TX) and the limitation of available donor kidneys, a detailed analysis of factors that shorten graft survival is important. Allograft rejection is a sterile inflammation of the transplant kidney triggered by underimmunosuppression and mediated by antibodies (ABMR) and/or T cells (TCMR) [2]. Complement is involved in immunologic (mediated by innate immunity) and inflammatory processes that further damage the graft. Complement activation is involved in many different renal diseases, such as complement component C3 (C3)-glomerulonephritis, IgA nephropathy, lupus nephritis, different thrombotic microangiopathies, and even diabetic kidney disease, which can recur after transplantation, demonstrating the unique susceptibility of the kidney to pathological complement effects [4,5]. It was natural to investigate whether complement-targeted strategies play a role in the outcome of renal transplantation, in terms of optimisation of graft quality, as well as in the treatment of ABMR, induction of accommodation, and modulation of the adaptive immune response
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have